S1P Receptor Agonist Intermediate Synthesis Without AlCl3 Contamination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing a key intermediate in the synthesis of sphingosine-1-phosphate receptor agonists face issues such as low yields, exothermic reactions, reactor contamination, and safety hazards due to the use of hazardous reagents like AlCl3, necessitating a safer and more efficient large-scale production process.
Innovation Solution
A method involving acetylation, Vilsmeier-Haack reaction, and deprotection steps is employed to prepare the intermediate compound of Formula 5, using safer reagents and mild conditions to achieve high yields, avoiding the use of AlCl3 and reducing the risk of reactor contamination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If AlCl3 is used in the existing synthesis method, then the reaction can proceed, but reactor contamination occurs and safety hazards arise
Solution Approach 1:
The patent removes AlCl3 from the reaction system entirely and replaces it with a catalytic amount of Lewis acid (0.01-0.1 eq) combined with a base additive. This extraction of the harmful substance while maintaining reaction functionality directly resolves the reactor contamination issue while preserving reaction reliability.
Solution Approach 2:
The patent introduces a base additive (triethylamine, diisopropylethylamine, or DBU) as an intermediary substance that works in conjunction with the catalytic Lewis acid to mediate the Vilsmeier-Haack reaction. This intermediary system achieves the desired reaction outcome without requiring stoichiometric AlCl3, thereby eliminating contamination while maintaining reaction reliability.
2Productivity
If existing synthesis methods are used, then the intermediate can be produced, but the yield is low and the process is complex
Solution Approach 1:
The patent optimizes reaction parameters including using catalytic amounts of Lewis acid (0.01-0.1 eq) instead of stoichiometric amounts, controlling reaction temperature (0-25°C), and selecting specific solvents (DCM, DCE, toluene, acetonitrile). These parameter changes streamline the process and improve yield while reducing complexity compared to existing multi-step methods.
Solution Approach 2:
The patent enables a continuous, efficient Vilsmeier-Haack reaction process where the catalytic Lewis acid system maintains active catalysis throughout the reaction without requiring workarounds or additional purification steps. This continuous useful action achieves high yields (70-90%) in a simplified single-step process.
3Productivity
If hazardous reagents are used in large-scale production, then the reaction can be driven forward, but safety hazards increase
Solution Approach 1:
The patent changes the quantity parameter of the Lewis acid from stoichiometric to catalytic amounts (0.01-0.1 eq), which dramatically reduces the amount of hazardous material required while maintaining reaction efficiency. This parameter change enables large-scale production with improved safety profiles.
Solution Approach 2:
The patent employs readily available, easy-to-handle base additives (triethylamine, diisopropylethylamine, DBU) that are less hazardous than AlCl3 and can be easily removed from the final product. These substitutes provide the necessary chemical functionality with reduced safety concerns for large-scale operations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables large-scale production of the intermediate compound in high yield under safe and stable conditions, eliminating reactor contamination risks and improving overall efficiency.
Implementation Method 1
a step of preparing a compound of Formula 4 by Vilsmeier-Haack reaction of the compound of Formula 3
Implementation Method 2
a step of preparing a compound of Formula 5 by removing an acetyl group from the compound of Formula 4
Data Source
AI summary
The present invention relates to a novel method for producing an intermediate expressed by chemical formula 5 that can be effectively used in synthesis of sphingosine-1-phosphate receptor agonist.